Clarissa Coffin, left, leans on Scott Wells, center, as he comforts his children next to Amanda Bouffioux's casket before her burial at the Anchorage Memorial Park Cemetery. Coffin, who was FaceTiming their mother, is Bouffioux's sister and Wells was Bouffioux's partner. (Emily Mesner / ADN) Scott Wells is grieving. And he is angry. His significant…
Anchorage The Copper River Seafoods plant on East First Avenue in Anchorage on Friday. (Anchorage Daily News photo) We're making coronavirus coverage available without a subscription as a public service. But we depend on reader support to do this work. Please consider joining others in supporting local journalism in Alaska for just $3.23 a week.…
Alaska News Crew members from the American Triumph are transported by bus from Seward to Anchorage on Wednesday, July 22, 2020. (Loren Holmes / ADN) We're making coronavirus coverage available without a subscription as a public service. But we depend on reader support to do this work. Please consider joining others in supporting local journalism…
Alaska News Alaska Airlines passenger jets at Ted Stevens Anchorage International Airport on Monday, June 22, 2020. (Bill Roth / ADN) We're making coronavirus coverage available without a subscription as a public service. But we depend on reader support to do this work. Please consider joining others in supporting local journalism in Alaska for just…
Anchorage The Providence Alaska Medical Center emergency department. (Loren Holmes / ADN file) We're making coronavirus coverage available without a subscription as a public service. But we depend on reader support to do this work. Please consider joining others in supporting local journalism in Alaska for just $3.23 a week. As Alaska’s coronavirus cases banked…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f